Business Wire | Nov 2, 2020 10:00AM EST

2nd Annual Gabelli Funds - Columbia Business School Healthcare Symposium (Virtual) - Friday, November 13, 2020

Nov. 02, 2020

GREENWICH, Conn.--(BUSINESS WIRE)--Nov. 02, 2020--Join us as we discuss today's pressing healthcare issues.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005244/en/

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

Bunny Ellerin Jing He

CO-HOSTS: Director, HPM, Columbia Business Biotech Analyst, Gabelli Funds School

* MBA, Columbia Business School * MBA, Harvard Business School * MA, Washington University in * BA, Columbia University St. Louis * BS, Peking University

Time Agenda

Welcome9:00 -9:10 AM * Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program

Vaccines & Therapeutics to Treat COVID-19

9:10 - * David Hering, Regional President, North America, Pfizer Vaccines10:00 AM * Dr. Robert Paris, Vice President, Infectious Diseases, Moderna * Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron * (Moderator) Jing He '15, Biotech Analyst, Gabelli Funds

Health Policy & Reimbursement Trends

* Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and10:10 - Chief Physician, NYP Medical Groups, NewYork-Presbyterian11:00 AM * Melissa Schulman, Senior Vice President of Government Affairs, CVS Health * Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health * (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds

Healthcare Delivery in a Virtual World

11:10 - * Dr. Amy Fahrenkopf, President, HSS Health and Senior ViceNoon President, Hospital for Special Surgery * Jason Gorevic, CEO, Teladoc Health * Dr. Julie Silverstein, Divisional President, Oak Street Health * (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

View source version on businesswire.com: https://www.businesswire.com/news/home/20201102005244/en/

CONTACT: Douglas R. Jamieson 914-921-5020 djamieson@gabelli.com